The ACCESS Study
Top Cited Papers
- 1 July 2003
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Stroke
- Vol. 34 (7), 1699-1703
- https://doi.org/10.1161/01.str.0000075777.18006.89
Abstract
Background and Purpose— The Acute Candesartan Cilexetil Therapy in Stroke Survivors (ACCESS) study was designed to assess the safety of modest blood pressure reduction by candesartan cilexetil in t...Keywords
This publication has 13 references indexed in Scilit:
- Assessment of Functioning and Disability After Ischemic StrokeStroke, 2002
- The Insula and Cerebrogenic Sudden DeathArchives of Neurology, 2000
- Acute Treatment of Ischemic StrokeCerebrovascular Diseases, 2000
- Renal protection by antihypertensive drugsJournal Of Hypertension, 1998
- Hypertension and stroke – rationale behind the ACCESS trialBasic Research in Cardiology, 1998
- Protective Effects of Candesartan Cilexetil (TCV-116) Against Stroke, Kidney Dysfunction and Cardiac Hypertrophy in Stroke-Prone Spontaneously Hypertensive RatsClinical and Experimental Hypertension, 1997
- ISIS-4: A randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58 050 patients with suspected acute myocardial infarctionThe Lancet, 1995
- Should Hypertension Be Treated After Acute Stroke?Archives of Neurology, 1993
- Effect of antihypertensive treatment on focal cerebral infarction.Hypertension, 1992
- Long-term benefit of early thrombolytic therapy in patients with acute myocardial infarction: 5 year follow-up of a trial conducted by the Interuniversity Cardiology Institute of the NetherlandsJournal of the American College of Cardiology, 1989